Total Payments
$12,302
2021 Payments
$1,301
Companies
38
Transactions
413
Medicare Patients
321
Medicare Billing
$55,141
Payment Breakdown by Category
Food & Beverage$12,248 (99.6%)
Education$53.87 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,248 | 408 | 99.6% |
| Education | $53.87 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,616 | 72 | $0 (2021) |
| AbbVie Inc. | $1,087 | 24 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $1,063 | 20 | $0 (2021) |
| GlaxoSmithKline, LLC. | $901.79 | 24 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $779.65 | 15 | $0 (2018) |
| Lilly USA, LLC | $759.09 | 36 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $686.24 | 27 | $0 (2021) |
| Amgen Inc. | $635.30 | 18 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $573.30 | 19 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $534.70 | 19 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,301 | 49 | Biohaven Pharmaceuticals, Inc. ($314.21) |
| 2020 | $1,296 | 69 | Novo Nordisk Inc ($270.74) |
| 2019 | $2,259 | 65 | Novo Nordisk Inc ($358.72) |
| 2018 | $3,700 | 102 | SANOFI-AVENTIS U.S. LLC ($570.94) |
| 2017 | $3,745 | 128 | Janssen Pharmaceuticals, Inc ($481.92) |
All Payment Transactions
413 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Diabetes | ||||||
| 09/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: DIABETES | ||||||
| 09/22/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 09/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: DIABETES | ||||||
| 08/04/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: PRIMARY CARE | ||||||
| 07/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 06/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $102.88 | General |
| Category: PRIMARY CARE | ||||||
| 06/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $102.88 | General |
| Category: PRIMARY CARE | ||||||
| 06/15/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $113.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Neuroscience | ||||||
| 06/04/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| Category: Neurology | ||||||
| 06/02/2021 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Respiratory | ||||||
| 05/28/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: NEUROLOGY | ||||||
| 05/26/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Diabetes | ||||||
| 05/14/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diabetes | ||||||
| 05/12/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/12/2021 | AbbVie Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROLOGY | ||||||
| 04/23/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 04/21/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 106 | 271 | $44,980 | $20,220 |
| 2020 | 5 | 215 | 629 | $105,150 | $34,921 |
Total Patients
321
Total Services
900
Medicare Billing
$55,141
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 193 | $29,375 | $13,424 | 45.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 78 | $15,605 | $6,796 | 43.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 76 | 340 | $59,500 | $18,698 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 45 | 45 | $13,725 | $5,622 | 41.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 60 | $12,000 | $5,020 | 41.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 49 | 49 | $9,800 | $4,026 | 41.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 135 | $10,125 | $1,555 | 15.4% |
About Dr. David Gilliam, M.D
Dr. David Gilliam, M.D is a Family Medicine healthcare provider based in Fairfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376526236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Gilliam, M.D has received a total of $12,302 in payments from pharmaceutical and medical device companies, with $1,301 received in 2021. These payments were reported across 413 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($12,248).
As a Medicare-enrolled provider, Gilliam has provided services to 321 Medicare beneficiaries, totaling 900 services with total Medicare billing of $55,141. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Fairfield, CA
- Active Since 11/23/2005
- Last Updated 06/27/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376526236
Products in Payments
- SOLIQUA (Drug) $671.76
- Ozempic (Drug) $670.28
- JARDIANCE (Drug) $643.50
- TRELEGY ELLIPTA (Drug) $491.09
- Victoza (Drug) $429.81
- INVOKANA (Drug) $422.88
- Creon (Drug) $387.72
- VRAYLAR (Drug) $387.71
- Aimovig (Biological) $356.88
- XARELTO (Drug) $350.75
- AJOVY (Drug) $347.26
- NURTEC ODT (Drug) $314.21
- TRULICITY (Drug) $304.86
- SYMBICORT (Drug) $263.56
- UBRELVY (Drug) $241.36
- ANORO (Drug) $240.27
- TOUJEO (Drug) $225.62
- FARXIGA (Drug) $225.09
- Tresiba (Drug) $216.05
- Proclaim Family of SCS IPGs (Device) $171.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fairfield
Dr. Dena Lacara, D.o, D.O
Family Medicine — Payments: $77,854
Family Medicine $77,854
Dr. Samuel Docena, M.d, M.D
Family Medicine — Payments: $5,485
Family Medicine $5,485
Mr. Craig Gillespie, Md, MD
Family Medicine — Payments: $4,330
Family Medicine $4,330
Steven Mitchell, M.d, M.D
Family Medicine — Payments: $4,315
Family Medicine $4,315
Elizabeth Sweet-Friend, M.d, M.D
Family Medicine — Payments: $3,544
Family Medicine $3,544
Dr. Richard Banks, Md, MD
Family Medicine — Payments: $3,184
Family Medicine $3,184